439 related articles for article (PubMed ID: 32824147)
1. The Development of High-Quality Multispecies Probiotic Formulations: From Bench to Market.
Grumet L; Tromp Y; Stiegelbauer V
Nutrients; 2020 Aug; 12(8):. PubMed ID: 32824147
[TBL] [Abstract][Full Text] [Related]
2. Bioinformatics-Based Tools and Software in Clinical Research: A New Emerging Area.
Bansal P; Arora M; Gupta V; Maithani M
Methods Mol Biol; 2019; 1939():215-230. PubMed ID: 30848464
[TBL] [Abstract][Full Text] [Related]
3. The Unregulated Probiotic Market.
de Simone C
Clin Gastroenterol Hepatol; 2019 Apr; 17(5):809-817. PubMed ID: 29378309
[TBL] [Abstract][Full Text] [Related]
4. Probiotic formulations and applications, the current probiotics market, and changes in the marketplace: a European perspective.
Saxelin M
Clin Infect Dis; 2008 Feb; 46 Suppl 2():S76-9; discussion S144-51. PubMed ID: 18181728
[TBL] [Abstract][Full Text] [Related]
5. Probiotics for the prevention of pediatric antibiotic-associated diarrhea.
Goldenberg JZ; Lytvyn L; Steurich J; Parkin P; Mahant S; Johnston BC
Cochrane Database Syst Rev; 2015 Dec; (12):CD004827. PubMed ID: 26695080
[TBL] [Abstract][Full Text] [Related]
6. Tackling probiotic and gut microbiota functionality through proteomics.
Ruiz L; Hidalgo C; Blanco-Míguez A; Lourenço A; Sánchez B; Margolles A
J Proteomics; 2016 Sep; 147():28-39. PubMed ID: 27003613
[TBL] [Abstract][Full Text] [Related]
7. Probiotics in Cosmetic and Personal Care Products: Trends and Challenges.
Puebla-Barragan S; Reid G
Molecules; 2021 Feb; 26(5):. PubMed ID: 33652548
[TBL] [Abstract][Full Text] [Related]
8. Beneficial microbiota. Probiotics and pharmaceutical products in functional nutrition and medicine.
Novik G; Savich V
Microbes Infect; 2020; 22(1):8-18. PubMed ID: 31233819
[TBL] [Abstract][Full Text] [Related]
9. Probiotics for the Prevention of Pediatric Antibiotic-Associated Diarrhea.
Hayes SR; Vargas AJ
Explore (NY); 2016; 12(6):463-466. PubMed ID: 27688016
[TBL] [Abstract][Full Text] [Related]
10. Probiotics: Versatile Bioactive Components in Promoting Human Health.
Sharifi-Rad J; Rodrigues CF; Stojanović-Radić Z; Dimitrijević M; Aleksić A; Neffe-Skocińska K; Zielińska D; Kołożyn-Krajewska D; Salehi B; Milton Prabu S; Schutz F; Docea AO; Martins N; Calina D
Medicina (Kaunas); 2020 Aug; 56(9):. PubMed ID: 32867260
[TBL] [Abstract][Full Text] [Related]
11. Too fast, too soon to call it "probiotic".
Miniello VL; Colasanto A; Diaferio L; Galizia IS; Jablonska J; Lauriero MA; Lieggi MS; Raimondi G; Santoiemma V; Sarcinella G; Simone R; Torrente P
Minerva Pediatr; 2010 Jun; 62(3 Suppl 1):105-7. PubMed ID: 21089729
[TBL] [Abstract][Full Text] [Related]
12. Commercial Probiotic Products: A Call for Improved Quality Control. A Position Paper by the ESPGHAN Working Group for Probiotics and Prebiotics.
Kolaček S; Hojsak I; Berni Canani R; Guarino A; Indrio F; Orel R; Pot B; Shamir R; Szajewska H; Vandenplas Y; van Goudoever J; Weizman Z;
J Pediatr Gastroenterol Nutr; 2017 Jul; 65(1):117-124. PubMed ID: 28644359
[TBL] [Abstract][Full Text] [Related]
13. The importance of guidelines in the development and application of probiotics.
Reid G;
Curr Pharm Des; 2005; 11(1):11-6. PubMed ID: 15638748
[TBL] [Abstract][Full Text] [Related]
14. Microbiological Testing of Probiotic Preparations.
Zawistowska-Rojek A; Zaręba T; Tyski S
Int J Environ Res Public Health; 2022 May; 19(9):. PubMed ID: 35565098
[TBL] [Abstract][Full Text] [Related]
15. Bringing a probiotic-containing functional food to the market: microbiological, product, regulatory and labeling issues.
Sanders ME; Huis in't Veld J
Antonie Van Leeuwenhoek; 1999; 76(1-4):293-315. PubMed ID: 10532385
[TBL] [Abstract][Full Text] [Related]
16. Effects of genetic, processing, or product formulation changes on efficacy and safety of probiotics.
Sanders ME; Klaenhammer TR; Ouwehand AC; Pot B; Johansen E; Heimbach JT; Marco ML; Tennilä J; Ross RP; Franz C; Pagé N; Pridmore RD; Leyer G; Salminen S; Charbonneau D; Call E; Lenoir-Wijnkoop I
Ann N Y Acad Sci; 2014 Feb; 1309():1-18. PubMed ID: 24571253
[TBL] [Abstract][Full Text] [Related]
17. Market and product assessment of probiotic/prebiotic-containing functional foods and supplements manufactured in South Africa.
Brink M; Senekal M; Dicks LM
S Afr Med J; 2005 Feb; 95(2):114-9. PubMed ID: 15751206
[TBL] [Abstract][Full Text] [Related]
18. Probiotic use in at-risk populations.
Sanders ME; Merenstein DJ; Ouwehand AC; Reid G; Salminen S; Cabana MD; Paraskevakos G; Leyer G
J Am Pharm Assoc (2003); 2016; 56(6):680-686. PubMed ID: 27836128
[TBL] [Abstract][Full Text] [Related]
19. Genome scale metabolic models and analysis for evaluating probiotic potentials.
Choi YM; Lee YQ; Song HS; Lee DY
Biochem Soc Trans; 2020 Aug; 48(4):1309-1321. PubMed ID: 32726414
[TBL] [Abstract][Full Text] [Related]
20. Modulation of immunity and inflammatory gene expression in the gut, in inflammatory diseases of the gut and in the liver by probiotics.
Plaza-Diaz J; Gomez-Llorente C; Fontana L; Gil A
World J Gastroenterol; 2014 Nov; 20(42):15632-49. PubMed ID: 25400447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
